Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings.  Hooker SA, Starkey C, Bart G, Rossom RC, Kane S, Olson AW.  BMC Prim Care. 2024 Oct 11;25(1):361. doi: 10.1186/s12875-024-02609-9. PM...

Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts.  Chatterjee A, Stewart EA, Assoumou SA, Chrysanthopoulou SA, Zwick H, Harris RA, O'Dea R, Schackman BR, White LF, Linas BP.  JAMA Netw Open. ...

Sex disparities in outcome of medication-assisted therapy of opioid use disorder: Nationally representative study.  Butelman ER, Huang Y, McFarlane A, Slattery C, Goldstein RZ, Volkow ND, Alia-Klein N.  medRxiv [Preprint]. 2024 Sep 26:...

USA. Is This Methadone’s Moment? Medscape - October 31, 2024. https://www.medscape.com/viewarticle/this-methadones-moment-2024a1000jy5

Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey.  Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Hagle H, Joudrey PJ, Molfenter T, Levin FR, Fiellin...

The Pre-Operative Evaluation Clinic: An Underutilized Service in Optimizing Analgesic Outcomes in Patients on Buprenorphine, Methadone, and Naltrexone for Substance Use Disorder or Chronic Pain.  Sand AE, Powell TE, Marry HT, Rathbun HR, Ste...